Unraveling the Signaling Dynamics of Small Extracellular Vesicles in Cardiac Diseases

Sheila Caño-Carrillo,Juan Manuel Castillo-Casas,Diego Franco,Estefanía Lozano-Velasco
DOI: https://doi.org/10.3390/cells13030265
IF: 6
2024-01-31
Cells
Abstract:Effective intercellular communication is essential for cellular and tissue balance maintenance and response to challenges. Cellular communication methods involve direct cell contact or the release of biological molecules to cover short and long distances. However, a recent discovery in this communication network is the involvement of extracellular vesicles that host biological contents such as proteins, nucleic acids, and lipids, influencing neighboring cells. These extracellular vesicles are found in body fluids; thus, they are considered as potential disease biomarkers. Cardiovascular diseases are significant contributors to global morbidity and mortality, encompassing conditions such as ischemic heart disease, cardiomyopathies, electrical heart diseases, and heart failure. Recent studies reveal the release of extracellular vesicles by cardiovascular cells, influencing normal cardiac function and structure. However, under pathological conditions, extracellular vesicles composition changes, contributing to the development of cardiovascular diseases. Investigating the loading of molecular cargo in these extracellular vesicles is essential for understanding their role in disease development. This review consolidates the latest insights into the role of extracellular vesicles in diagnosis and prognosis of cardiovascular diseases, exploring the potential applications of extracellular vesicles in personalized therapies, shedding light on the evolving landscape of cardiovascular medicine.
cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the signal transduction dynamics of small extracellular vesicles (sEVs) in heart diseases, specifically including the following aspects: 1. **Understanding the role of sEVs in the diagnosis and prognosis of heart diseases**: The paper aims to summarize the latest insights into the role of sEVs in the diagnosis and prognosis of cardiovascular diseases (such as myocardial infarction, heart failure, atrial fibrillation, hypertrophic cardiomyopathy, dilated cardiomyopathy, and diabetic cardiomyopathy, etc.), and explore their potential as disease biomarkers. 2. **Studying the mechanisms of sEVs in the development of heart diseases**: The paper analyzes in detail how sEVs participate in the pathological processes of heart diseases by carrying specific molecular cargos (such as miRNA, lncRNA, circRNA, and proteins, etc.), especially their roles in key processes such as inflammation, fibrosis, angiogenesis, and apoptosis after myocardial infarction. 3. **Exploring the potential application of sEVs in personalized treatment**: The paper also discusses the potential application of sEVs in the treatment of cardiovascular diseases, especially the possibility as drug - delivery carriers, by loading specific non - coding RNAs or other molecules to promote heart repair and functional recovery. In summary, the main purpose of this paper is to reveal the multiple roles of sEVs in heart diseases by integrating existing research results, and to provide new ideas and methods for future cardiovascular disease diagnosis, prognosis, and treatment.